1. Wang, Ru, Godet, Ines, Yang, Yongkang, Gilkes, Daniele M, Semenza, Gregg L. . Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. In Proceedings of the National Academy of Sciences of the United States of America, 118, . doi:10.1073/pnas.2020490118. https://pubmed.ncbi.nlm.nih.gov/33952697/
2. Di Carlo, Selene E, Raffenne, Jerome, Varet, Hugo, Bousquet, Corinne, Peduto, Lucie. 2023. Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis. In Nature immunology, 24, 1867-1878. doi:10.1038/s41590-023-01642-7. https://pubmed.ncbi.nlm.nih.gov/37798557/
3. Ren, Kewei, Ruan, Yuan, Tang, Jilei, Gu, Yanqing, Mi, Yuanyuan. 2017. Association of ADAM12 gene polymorphisms with knee osteoarthritis susceptibility. In Oncotarget, 8, 77710-77721. doi:10.18632/oncotarget.20772. https://pubmed.ncbi.nlm.nih.gov/29100419/
4. Duhachek-Muggy, Sara, Zolkiewska, Anna. 2015. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer. In BMC cancer, 15, 93. doi:10.1186/s12885-015-1108-1. https://pubmed.ncbi.nlm.nih.gov/25886595/
5. Xu, Jinming, Wang, Yan, Jiang, Jiahao, Yin, Cong, Shi, Bentao. 2023. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. In Journal of translational medicine, 21, 56. doi:10.1186/s12967-023-03913-1. https://pubmed.ncbi.nlm.nih.gov/36717944/
6. Mohamad, Amira, Hassan, Rosline, Husin, Azlan, Johan, Muhammad Farid, Sulong, Sarina. 2021. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique. In Asian Pacific journal of cancer prevention : APJCP, 22, 85-91. doi:10.31557/APJCP.2021.22.1.85. https://pubmed.ncbi.nlm.nih.gov/33507683/
智鼠故事 
